Summary of Purpose
Ischemic stroke is the first cause of acquired disability of the adult, the second cause of dementia and the third cause of death in the industrialized countries, what constitutes à major public health issue. Stroke is characterized by a cerebral parenchymal lesion due to an ischemic mechanism (85% of the cases) or hemorrhagic mechanism (15%). For a long time, the only approved treatment was the intravenous...Read More →
The following dates are available for this trial. Trial information last updated on 9 May 2017.
|13 Oct 2016||9 May 2017||4 May 2017||1 Oct 2026||1 May 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|